Table I.
Clinical data of neonatal patients in the treatment and control groups [n (%)].
| Items | Treatment group | Control group | χ2/t-test | P-value |
|---|---|---|---|---|
| Sex | χ2=3.208 | 0.326 | ||
| Male | 28 (46.67) | 34 (56.67) | ||
| Female | 32 (53.33) | 26 (43.33) | ||
| Gestational age | χ2=2.264 | 0.431 | ||
| ≤38 weeks | 23 (38.33) | 28 (46.67) | ||
| >38 weeks | 37 (61.67) | 32 (53.33) | ||
| Weight | χ2=3.681 | 0.201 | ||
| ≤3400 g | 37 (61.67) | 33 (55.00) | ||
| >3400 g | 23 (38.33) | 27 (45.00) | ||
| Age (years) | χ2=3.051 | 0.289 | ||
| ≤16 days | 36 (60.00) | 39 (65.00) | ||
| >16 days | 24 (40.00) | 21 (35.00) | ||
| Delivery mode | χ2=3.161 | 0.243 | ||
| Eutocia | 43 (71.67) | 47 (78.33) | ||
| Cesarean | 17 (28.33) | 13 (21.67) | ||
| Family address | χ2=2.930 | 0.304 | ||
| Urban area | 49 (81.67) | 41 (68.33) | ||
| Rural area | 11 (18.33) | 19 (31.67) | ||
| Serum sodium (mmol/l) | 135.16±6.12 | 133.26±5.37 | t=5.316 | 0.159 |
| Serum calcium (mmol/l) | 2.20±0.49 | 2.35±0.24 | t=4.161 | 0.198 |